Administration of Eculizumab, a C5 Inhibitor, for the Treatment of Shiga-Toxin-Producing <i>Escherichia coli</i> Infection: A Case Report | Zendy

AI Assistant Blog Pricing

Administration of Eculizumab, a C5 Inhibitor, for the Treatment of Shiga-Toxin-Producing <i>Escherichia coli</i> Infection: A Case Report

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.